PDLIM4 anticorps (N-Term)
Aperçu rapide pour PDLIM4 anticorps (N-Term) (ABIN5516869)
Antigène
Voir toutes PDLIM4 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- N-Term
-
Séquence
- VTLRGPSPWG FRLVGGRDFS APLTISRVHA GSKAALAALC PGDLIQAING
-
Purification
- Affinity purified
-
Immunogène
- The immunogen is a synthetic peptide directed towards the N terminal region of human PDLIM4
-
-
-
-
Indications d'application
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Liquid. Purified antibody supplied in 1x PBS buffer with 0.09 % (w/v) sodium azide and 2 % sucrose.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- For short term use, store at 2-8°C up to 1 week. For long term storage, store at -20°C in small aliquots to prevent freeze-thaw cycles.
-
-
- PDLIM4 (PDZ and LIM Domain 4 (PDLIM4))
-
Autre désignation
- PDLIM4
-
Sujet
-
This gene encodes a protein which may be involved in bone development. Mutations in this gene are associated with susceptibility to osteoporosis.
Alias Symbols: RIL
Protein Size: 330 -
ID gène
- 8572
-
NCBI Accession
- NM_001131027, NP_001124499
-
UniProt
- P50479
Antigène
-